Niyati Kandikanti

Niyati Kandikanti

Auto-generated profile, based on publicly available information

Niyati Kandikanti

Faculty of Medicine and Health Technology, Tampere University, 33014 Tampere

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2024 in Journal of Advanced Research
Verified
Journal Article
Open access
SMSurbhi Mishra
Surbhi Mishra
MTMysore Vishakantegowda Tejesvi
Mysore Vishakantegowda Tejesvi
JHJenni Hekkala
Jenni Hekkala
JTJenni Turunen
Jenni Turunen
NKNiyati Kandikanti
Niyati Kandikanti
JRJustus Reunanen
Justus Reunanen
Gut microbiome-derived nanoparticles, known as bacterial extracellular vesicles (bEVs), have garnered interest as promising tools for studying the link between the gut microbiome and human health. The diverse composition of bEVs, including their proteins, mRNAs, metabolites, and lipids, makes them useful for investigating diseases such as cancer. However, conventional approaches for studying gut microbiome composition alone may not be accurate in deciphering host-gut microbiome communication. In clinical microbiome research, there is a gap in the knowledge on the role of bEVs in solid tumor patients. Analyzing the functionality of bEVs using (meta)genomics and proteomics could highlight the unique aspects of host-gut microbiome interactions in solid tumor patients. Therefore, we performed a comparative analysis of the proteome and microbiota composition of gut microbiome-derived bEVs isolated from patients with solid tumors and healthy controls. After isolating bEVs from the feces of solid tumor patients and healthy controls, we performed spectrometry analysis of their proteomes and next-generation sequencing (NGS) of the 16S gene. We also investigated the gut microbiomes of feces from patients and controls using 16S sequencing and used machine learning to classify the samples into patients and controls based on their bEVs and fecal microbiomes. Solid tumor patients showed decreased microbiota richness and diversity in both the bEVs and feces. However, the bEV proteomes were more diverse in patients than in the controls and were enriched with proteins associated with the metabolism of amino acids and carbohydrates, nucleotide binding, and oxidoreductase activity. Metadata classification of samples was more accurate using fecal bEVs (100%) compared with fecal samples (93%). Our findings suggest that bEVs are unique functional entities. There is a need to explore bEVs together with conventional gut microbiome analysis in functional cancer research to decipher the potential of bEVs as cancer diagnostic or therapeutic biomarkers.

13 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
PKPauliina Kukkoaho
Pauliina Kukkoaho
MAMaria Annala
Maria Annala
MKMarika Kosunen
Marika Kosunen
HKHelka Kaunisto
Helka Kaunisto
KTKaroliina Tanner
Karoliina Tanner
KJKati Juuti-Uusitalo
Kati Juuti-Uusitalo
Background & Aims: Celiac disease is a wheat-induced immune-mediated enteropathy characterized by cytokine, especially IFNγ upregulation. Intestinal organoid models for adult stem cell–based celiac disease exist, but planar iPSC based small intestinal epithelial models derived from celiac disease patients that would allow direct assessment from both sides of the epithelium have been lacking. We aimed to bridge this gap by setting up a two-dimensional in vitro model based on small intestinal epithelial cells derived from iPSC from celiac disease patient. Methods: IPSCs from celiac disease patient and control patient were directly differentiated into small intestinal epithelium on Transwell inserts without intermediate organoid phase or replating. Model maturity and celiac disease specific cytokine responses were analysed using immunofluorescence, transcriptomic profiling, and LDH cytotoxicity assay. Results: Two-dimensionally cultured c eliac disease derived line and control patient derived iPSCs matured similarly towards intestinal epithelium which expressed enterocyte specific PEPT1 and EpCAM. To the cytokine stimuli, celiac and healthy iPSC-SIECs responded by increasing the expression IRF1, ICAM1 and IDO1, and several other known cytokine responsive genes. Conclusions: These findings suggest that the 2D iPSC celiac disease small intestinal epithelium model represent an appropriate platform for studying inflammation-associated enteropathies, such as celiac disease.